Acute cor pulmonale (ACP) is a common sequela in patients with acute respiratory distress syndrome (ARDS) and represents the most severe presentation of right ventricular dysfunction, secondary to pulmonary vascular dysfunction. Although most previous studies adopted transesophageal echocardiography in the diagnosis of ACP in patients with ARDS, transthoracic echocardiography (TTE) appears as a promising alternative, being noninvasive and more available with continuously improving expertise in its use by ICU physicians.
Introduction
Acute cor pulmonale (ACP) is the most severe presentation of right ventricular (RV) dysfunction, secondary to pulmonary vascular dysfunction [1, 2] . ACP is a frequent and usually lethal complication of acute respiratory distress syndrome (ARDS) [3, 4] . Two factors cause RV overload inducing ACP in ARDS: the pathologic features of the ARDS itself and mechanical ventilatory management [5] . The most widely accepted definition of ARDS was the American European Consensus Conference (AECC) definition; however, its diagnostic accuracy was questionable [6] . So, many subsequent modifications were published under the term of 'Berlin definition' in 2011 [7] . Mekontso-Dessap et al. [8] used transesophageal echocardiography (TEE) to determine the incidence of ACP, and create a clinical risk score 'ACP risk score' to predict the presence of ACP and determine the association of ACP with mortality in patients with ARDS. ACP clinical risk score (1 point for each parameter) includes the following: pneumonia, hypercapnia with arterial carbon dioxide tension (PaCO 2 ) of at least 48 mmHg, driving pressure (ΔP) of at least 18 cmH 2 O, or arterial oxygen tension/fractional inspired oxygen (PaO 2 /FiO 2 ) less than 150 mmHg.
Echocardiography is the 'gold standard' tool to diagnose early RV dysfunction in ARDS, either TEE or transthoracic echocardiography (TTE) approach [9] . There are always limitations to use TEE in daily routine practice as it is invasive and most of the ICU physicians are skilled in its use, and TEE may be also contraindicated in some patients. Alternatively, TTE is noninvasive, more suitable for follow-up, and more practical to use, with continuously improving expertise in its use by the ICU physicians [10] .
The main objectives of our study were to determine the incidence of ACP among patients with ARDS, who were admitted to the Critical Care Medicine Department, and to test the sensitivity and specificity of ACP clinical risk score when TTE was used in the diagnosis of ACP.
Patients and methods

Patients
This study was conducted on patients with ARDS who were admitted to Critical Care Medicine Department over 6 months (between June 2016 and December 2016) and had been diagnosed according to 'Berlin definition' of ARDS.
Inclusion criteria included patients older than 18 years, who had been diagnosed to have ARDS according to the 'Berlin definition' and mechanically ventilated according to ARDSnet protocol. Exclusion criteria included a patient who refused to be involved, pregnancy, previous history of pulmonary hypertension, pulmonary embolism, deep vein thrombosis, history of chronic pulmonary disease requiring long-term oxygen therapy or home mechanical ventilation (MV), and patients in prone positioning.
Approval of the Medical Ethics Committee of Alexandria Faculty of Medicine had been taken. An informed consent from patients or their first-degree relatives had been taken before their enrollment in the study.
Methodology
Our study is a prospective observational cross-sectional study that was carried out over 6 months in our department. Screening of 125 mechanically ventilated critically ill patients in ICU was done to identify ARDS cases according to Berlin definition, and 45 patients with ARDS were identified. TTE was performed to diagnose ACP cases and test different parameters.
All patients with ARDS were mechanically ventilated according to conventional lung-protective strategy of ARDSnet protocol. MV data regarding positive endexpiratory pressure (PEEP), plateau pressure (Pplat.), and ΔP had been recorded just at the time of TTE. Echocardiography TTE was done by an expert consultant within 72 h of ARDS diagnosis. ACP according to echocardiographic criteria were defined as a RV dilatation when the ratio of RV/left ventricular end-diastolic area more than 0.6 in parasternal short-axis view or apical four chambers view, 'indicating RV diastolic overload', associated with interventricular septum dyskinesia in parasternal shortaxis or long-axis view at the mitral valve or papillary muscle level at end-systole, 'indicating RV systolic overload', associated with interventricular septum dyskinesia on a parasternal short-axis or long-axis view at the mitral valve or papillary muscle level at end-systole, 'indicating RV systolic overload'. A ratio that ranges between 0.6 and 1 denotes mild-tomoderate RV dilatation, whereas a ratio more than one denotes severe RV dilatation [9, 10] .
Subgroup analysis was done according to the following:
(1) The presence of ACP.
(2) The ACP clinical score.
(3) The severity of ARDS (mild, moderate, and severe). 
Results
Patient's characteristics
In this observational study, 125 mechanically ventilated critically ill patients were screened according to 'Berlin criteria' of ARD, where 36% (n=45) represented patients with ARDS versus 64% (n=80) represented patients without ARDS. Patients with ARDS included 25 female and 20 male patients, with a mean age of 41.3±14.6 years. ACP according to the echocardiographic criteria was detected in only 10 patients with ARDS (incidence among patients with ARDS was 22.2%) and in 15 patients without ARDS (incidence among patients without ARDS was 18.8%). ACP was not significantly different between patients with ARDS and patients without ARDS (P=0.64). Age, sex, height, and predicted body weight were not significantly different between patients with or without ACP ( Table 1) .
Hemodynamic findings
In overall study, shock was observed in 80% of patients with ARDS (n=36). Although patients with ACP manifested high incidence of shock at the time of TTE, there was no significant difference between patients with and without ACP (100 vs. 74%, respectively, FE P=0.173) ( Table 1) . The risk factors of ARDS can be divided into pulmonary (direct) and extrapulmonary (indirect) risk factors. Indirect causes were more common than direct causes. Sepsis-inducing ARDS resulted from complex events, from either direct or indirect causes. Sepsis was observed in 91.1% of patients with ARDS. Pneumonia was the most common direct risk factors of ARDS. Shock was the most common indirect risk factor of ARDS. In the overall study, shock was generally considered as the most common risk factor of ARDS, as it was identified in 80% (n=36) of patients with ARDS. The most predominant risk factors of ACP complicating patients with ARDS were shock and pneumonia, representing in 100 and 90% of patients with ACP, respectively. Pneumonia was considered as the only significant major risk factor in ACP complicating patients with ARDS ( FE P=0.029) ( Table 3) . . ACP incidence associated with ACP score 0, 1, 2, 3, and 4 was 0, 0, 10, 50, and 40%, respectively, and score of at least 2 was reported in 100% of patients with ACP versus 48% of patients without ACP (P=0.002, MC P=0.019). ACP risk score with cutoff value of at least 2 showed high sensitivity (100%), average specificity (51.43%), and good accuracy (62.2%) in prediction of ACP cases with a reasonable discrimination between patients with or without ACP [receiver operating characteristic (ROC) curve; area under the curve (AUC)=0.809; 95% confidence interval=0.684-0.934; P=0.003] ( Table 4 ).
Outcome
The 28-day mortality rate in patients with ARDS in our study was 66.7% (n=30), whereas 28-day mortality of ACP in patients with ARDS was 33.33% (n=10). ACP complicating moderate to severe ARDS had a significant effect on mortality, as all ACP cases did not survive ( FE P=0.019) ( Table 5 ). Although age and sex had no significant effect on incidence of ACP, both exerted a significant effect on mortality in this study Correlation between different plateau pressure levels, severity, mortality rate and incidence of acute cor pulmonale in ARDS. O, which was associated with increased survival rates, considering mean PEEP less than 12 cmH 2 O to have survival benefit in this study (P<0.001). ACP risk score of at least 2 was associated with increased mortality rates among patients with ARDS, as 28-day mortality reached up to 83.4% with score of at least 2 ( MC P<0.001). The 28day mortality rates associated with ACP score 0, 1, 2, 3 , and a mean PaO 2 /FiO 2 of 100.8±41 mmHg (P<0.001) had been significantly associated with increased 28-day mortality rates among patients with ARDS. The severity of hypoxia had a bad prognostic effect in this study. Both moderate and severe ARDS subgroups were highly associated with higher mortality rates as 28-day mortality was increased as follows: 0.0, 30.0 and 70.0% in correlation with ARDS subgroups mild, moderate, and severe, respectively (P<0.001) ( Tables 5 and 6 , Fig. 2 ).
Discussion
The incidence of acute respiratory distress syndrome and acute cor pulmonale
In this study, 36% of mechanically ventilated critically ill patients were diagnosed as patients with ARDS according to 'Berlin definition' of ARD. Most of the data collected from previous studies depended on 'AECC criteria' and not on 'Berlin definition' of ARDS. So, many discrepancies between these studies had been predicted. Incidence of ARDS in critically ill patients in most previous studies that used 'AECC criteria' was 3.6-25%, and in recent studies that used Berlin definition was 1.8-33.3% [11] . Incidence of ARDS reported in two Brazilian studies was 1.8 and 31% by using 'Berlin definition' [12, 13] . Incidence of ARDS reported in a large Argentinian study was 7.7% by using 'AECC criteria' [14] . Cumulative incidence obtained from multicentric American reviews was 33.3% [15] . In 2014, a multicentric international study (LUNG SAFE) published an incidence of ARDS in 10.4% of all ICU admission and 23.4% of all patients requiring MV, with reporting geographic variations, being the highest in North America and Europe and the least in Asia and Africa [16] . Bauman et al. [17] mentioned much higher incidence of ARDS up to 52.6%, depending on the use of 'Berlin definition' of ARDS.
Regarding ACP incidence, ACP was detected in 22.2% of patients with ARDS in our study. Earlier studies in 1980s reported higher ACP incidence up to 60% by using TTE [9] . Similar results had been demonstrated by Viellard-Baron et al. [1, 2] , and Lheritier et al. [18] . Few years later, [19] published a higher incidence in patients with severe ARDS up to 50%. Brown et al. [20] found the highest ACP incidence up to 84% by using TTE in patients with H1N1-related ARDS according to 'AECC criteria'. Lately, Boissier et al. [21] and Mekontso-Dessap et al.
[22] also published similar ACP incidence of 22 and 20.4%, respectively, in patients with ARDS according to 'Berlin definition'. In 2016, similar results were also found by Mekontso-Dessap et al. [8] with ACP incidence of 21.8%.
Risk factors of acute respiratory distress syndrome and acute cor pulmonale
Pneumonia was the most common direct risk factor of ARDS in our study, which is similar to many other Correlation between the severity of ARDS, mortality rate and incidence of acute cor Pulmonale in ARDS.
studies. A study done in Canada found that 58% of ARDS cases experienced pneumonia [24] . Less incidence was mentioned in a study done in the USA, as pneumonia was found in 43% of cases [24] . In India, Magazine et al. [25] and Vigg et al. [26] also found less incidence of pneumonia in 23 and 30% of ARDS cases, respectively. Many similarities had been demonstrated by Durbesula et al. [27] , where sepsis was the predominant risk factor of ARDS in more than 90% of ARDS cases, and pneumonia was the most common direct risk factor of ARDS in both studies. However, direct septic causes were more common than indirect septic causes, which is opposite to our results. The most predominant risk factors of ACP in patients with ARDS were shock and pneumonia. Pneumonia was considered as the only significant major risk factor in ACP complicating patients with ARDS in our study, whereas Boissier et al. [21] declared that both pneumonia and shock were the only significant risk factors of ACP complicating patients with ARDS (P=0.03, 0.01).
Outcome
Our results declare that 28-day mortality rate among patients with ARDS was high up to 66.7%. Mortality rates among patients with ARDS in previous studies were higher, but over the time, there was a decreasing trend. In the 1980s, ARDS mortality rates ranged between 60 and 80%, and it gradually decreased to 30-40% in the 2000s [8, 9] . A retrospective review on patients with ARDS between 1990 and 1998 found a significant decrease in mortality rates from 70 to 51.5% [28] . In 2005, ARDS network published lesser mortality rate of 26% in ARDS [29] . In developed countries, mortality rates were less than in developing countries owing to the improvement in the ventilatory management strategies, although there was a decreasing trend observed since the 2000s in both [30, 31] . However, recent studies in developed countries showed upward increase in mortality rates despite improvement in medical treatment, such as the studies published by Villar et al. [32] and Amato et al. [33] , as mortality rates increased up to 53 and 71%, respectively. Our results showed that ACP had a significant effect on 28-day mortality in patients with ARDS, as all ACP complicating moderate to severe ARDS cases had not survived. Boissier et al. [21] declared that 28-day mortality in ACP was 60%, and ACP exerted a significant effect on mortality (P=0.01). Studies published by Vieillard-Baron et al. [34] and Lhéritier et al. [18] on prone positioning in severe ARDS showed a higher survival benefit of prone positioning. Mekontso-Dessap et al. [22] did not find any significant effect of mild-to-moderate ACP on mortality, although only severe ACP had a significant relation with 28-day mortality (P<0.03).
Female patients were more common than male patients in ARDS and ACP patients in our study, despite more prevalence in male patients was found in most previous studies. However, there was no significant effect of sex on ACP development described in these studies similar to our results [8, 18, 21, 22] . Moreover, female patients had been associated with higher mortality rate than male patients, although the reverse was also mentioned by most studies [8, 21, 22] . The mean age of 41.3±14.6 years was associated with patients with ARDS in our study. However, results mentioned by previous studies were higher, as mean age older than 55 years was demonstrated by Irish trials in ARDS and mean age older than 60 years was published in many western studies [30, 35, 36] . Age was not significantly different between patients with or without ACP, but it was significantly associated with increased mortality rates in our study, similar to many studies [8, 18, 21, 22] . All patients with ACP in this study experienced shock.
Boissier et al. [21] and Lhéritier et al. [18] reported incidence of shock associated with patients with ACP in 64 and 86% of cases, respectively, and found a significant relation in between (P<0.01), whereas Mekontso-Dessap et al. [22] did not show any significant relation in between ACP and shock (P=0.5). The overall 28-day mortality was high up to 83.3% in shocked patients with ARDS, and it was considered as an independent significant risk factor for 28-day mortality in patients with moderate to severe ARDS as many other studies [8, 18, 21, 22] .
Respiratory findings
Our results expressed a significant correction between increasing ACP incidence and mortality rates with increasing Pplat., as correlated ACP incidence was 0, 10.0 and 90.0% and 28-day mortality was 3.3, 16.7 and 80.0% when patients with ARDS were subdivided into three subgroups according to the Pplat.: <25, 25-30, and >30 cmH 2 O, respectively. Jardin et al. [9] could prove a correlation between increased Pplat. and increased incidence of ACP, as ACP incidence was 20, 39, and 42% in relation to Pplat. subgroups 18-26, 27-35 and >35 cmH 2 O, respectively, although mortality rates have not been discussed throughout that study. Later on, Viellard-Baron et al. [1] found similar results in patients with moderate to severe ARDS, as incidence of ACP was 13, 32, and 56% and the 28-day mortality was 13, 42, and 80% in relation to Pplat. subgroups 18-26, 27-35, and >35 cmH 2 O, respectively. Eichacker and colleagues [37, 38] published the concept of 'one size does not fit all', considered that both excessive reduction or elevation in Pplat. might increase mortality in patients with ARDS; however, keeping Pplat. less than 28 cmH 2 O in patients with ARDS had a survival benefit. Most studies also verified that increasing Pplat. had a significant effect on ACP development and 28-day mortality [8, 18, 19, 21, 22] .
Effect of PEEP on pulmonary circulation and RV function depends on the balance between recruitment and over-distension induced by it [19] . Our results exhibited a significant effect of PEEP on ACP development and increased mortality rates among patients with ARDS (P=0.002). Guervilly et al. [39] and Lhéritier et al. [18] reported similar mean PEEP values associated with ACP of 13±3 and 11±3 cmH 2 O, respectively, whereas Bossier et al. [21] and Mekontso-Dessap et al. [22] reported lesser values associated with ACP of 8.8±3 and 8±4 cmH 2 O, respectively. In 2004, ARDS network failed to investigate the role of high PEEP on outcome of patients with ARDS as best PEEP could not be figured out, regarding severity of ARDS or survival [40] . Ranieri et al. [7] and Talmor et al. [41] reported reduction in mortality rates with application of high PEEP in ARDS. Recently, a recommendation to reserve the application of high PEEP to only patients with severe ARDS according to 'the ARDS definition task force' was published [7] . Bull et al. [42] and Lhéritier et al. [18] reported that increasing PEEP had no significant effect on mortality rates (P=0.59 and 0.88, respectively). In recent meta-analysis trials (from 1996 to 2010), which compared the effect of higher versus lower levels of PEEP on mortality, the only difference in mortality between both was reported in severe ARDS (hypoxic index, HI<200 mmHg), as application of higher levels of PEEP had a survival benefit [25] .
Acute cor pulmonale risk score and its parameters Mekontso-Dessap et al. [8] developed a clinical risk score to predict ACP cases in patients with ARDS. The prevalence of ACP in association with ACP risk scores of 0, 1, 2, 3, 4 was 7, 10, 19, 35, and 75% in the derivation cohort and 7, 10, 20, 32 and 73% in the validation cohort, respectively, with a reasonable discrimination ability and good calibration for detecting early ACP cases (ROC; AUC=0.73; 95% CI=0.67-0.78; P<0.001 and ROC; AUC=0.70; 95% CI=0.62-0.78; P<0.001, respectively). So, echocardiography was recommended as a routine to diagnose ACP when the risk score is at least 2 and to adjust MV settings to decrease RV afterload and avoid any further deterioration toward severe ACP.
Our results demonstrated that ACP incidence associated with ACP score of 0, 1, 2, 3, and 4 was 0, 0, 10, 50, and 40%, and score of at least 2 was reported in 100% of patients without ACP versus 48% of patients without ACP (P=0.002, MC P=0.019). ACP risk score with cutoff value of at least 2, showed high sensitivity (100%), average specificity (51.43%), and good accuracy (62.2%) in prediction of ACP cases with a reasonable discrimination between patients with or without ACP (ROC; AUC=0.809; 95% CI= 0.684-0.934; P=0.003). Moreover, the 28-day mortality associated with ACP score of 0, 1, 2, 3, and 4 was 3.3, 13.3, 16.7, 36.7, and 30.0%, respectively, and mortality reached up to 83.4% was associated with score of at least 2 ( MC P<0.001).
All parameters of ACP risk score had a significant effect on ACP development and 28-day mortality in this study. Pneumonia was considered as a major independent risk factor of ACP incidence and 28day mortality in patients with moderate and severe ARDS similar to many other studies [8, 18, 21, 22] . It was identified in 90% of patients with ACP, and overall mortality was 76.7% in patients with pneumonia. Mekontso-Dessap et al. [8] , Lhéritier et al. [18] , and Boissier et al. [21] reported pneumonia in 58, 63, and 67% of ACP complicating patients with ARDS, respectively, and it exerted a significant effect on ACP development in all of these studies (P<0.001, <0.04, and 0.03, respectively). Zilberberg et al. [43] documented that pneumonia had a significant effect on mortality, as mortality was 43% in patients with pneumonia (P<0.05). However, Chastre et al. [44] recorded pneumonia in 55.3% of patients with ARDS but did not report any significant increase in mortality in such patients. Over the past 20 years, the main objective in ventilatory management in patients with ARDS was to maintain PaCO 2 in the normal range. In the 1990s, with application of a lung-protective approach, permissive hypercapnia had been allowed, whereas the trend of 'Airway pressure limitation' was introduced [45, 46] . Hypercapnia is a powerful vasoconstrictor of the pulmonary circulation, and its effects had been more understood since the beginning of the 2000s [47] . Hypercapnia was considered as an independent risk factor associated with ACP development and 28-day mortality in patients with moderate to severe ARDS, similar to most studies [1, 8, 17, 18, 21, 22] . Driving pressure is described as follows: ΔP=Pplat.−PEEP). It is considered as a distending pressure, which is related to the ventilatory strategy and to the severity of ARDS [21] . Any increase in ΔP could exaggerate the deleterious effect of lung distension on pulmonary capillaries and consequently impair RV afterload and function [48] . Many authors explained the significant effect of increased ΔP on ACP development, similar to our results [8, 18, 21, 22] . Recently, ΔP had been described as the best predictor of survival in patients with ARDS. Amato et al. [49] exhibited that increased ΔP was associated with increased mortality rates (P<0.001), similar to data published by Boissier et al. [21] and Mekontso-Dessap et al. [22] . Subsequently, Villar et al. [50] noticed that survival rates had been decreased, when ΔP is at least 19 cmH 2 O and Pplat. is more than 30 cmH 2 O. Hypoxia has a pulmonary vasoconstrictor effect as well and could increase pulmonary vascular dysfunction in patients with ARDS, inducing ACP. All patients with ACP in this study belonged to severe ARDS group (PaO 2 /FiO 2 ≤100 mmHg), and the mean PaO 2 /FiO 2 ratio of 76.60±13 mmHg was significantly associated with patients with ACP (P<0.001). Similarly, Mekontso-Dessap et al. [21] reported a significant effect of hypoxia on ACP development, as mean PaO 2 /FiO 2 of 106±40 mmHg was reported in patients with ACP (P<0.01), although some studies failed to report any significant effect of hypoxia on ACP development [18, 21] . Enson et al. [51] were the first to report that with more increase in hypoxia, less survival rate was found. The severity of hypoxia had a bad prognostic effect in our study, and it was considered as a major independent risk factor of 28-day mortality in patients with ARDS, similar to previous studies [8, 18, 21, 22] . Both moderate and severe ARDS subgroups were highly associated with higher mortality rates, as 28-day mortality was 0.0, 30.0, and 70.0% in relation to ARDS subgroups mild, moderate, and severe, respectively (P<0.001). The 28day mortality rates published by Ranieri et al. [7] and Villar et al.
[52] increased as follows: 27, 32, and 45% and 17, 40.9, and 58.1%, respectively, in relation to mild, moderate, and severe ARDS subgroups, respectively.
Study limitation
This study has some limitations. First, TTE is still an operator-dependent tool, same as TEE. Second, these results published by our study depended on only single echocardiographic assessment and were not supported by frequent assessment and follow-up of RV. Third, the whole sample size was small and the number of ACP cases was limited.
Conclusion
ACP risk score is a highly sensitive score in predicting and diagnose of ACP in patients with ARDS. TTE has a promising role in identification of ACP cases and could be widely used by ICU physicians in practice. Hypoxia, hypercapnia, sepsis, and increased ΔP had a strong association with ACP development and 28-day mortality in patients with ARDS.
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